Top line: In the treatment of weight relapse after metabolic bariatric surgery (MBS), semaglutide 1.0 mg/week produced greater weight loss than liraglutide 3.0 mg/day. methodology: This...
this The study was announced It has been posted on medRxiv.org as a preprint and has not yet been peer reviewed. Important point A review of...
Members of the medical and social research community voiced in support of: NHS Digital’s GP Data for Planning and Research (GPDPR) Program After the government confirms...
Recent Comments